A review of current and emerging treatments for diabetic macular oedema and macular oedema sec...
    
    
        
            5 September 2012
            Volume 13, Issue 3
            
         
        A discussion of current and emerging treatments  for diabetic retinopathy, diabetic maculopathy, central retinal vein occlusion and branch retinal vein occlusion. 
     
    
    
    
        
            
                
    
Introduction    
    
        With the number of people having diabetes set to increase significantly, the burden of treating the complications of diabetic retinopathy is a major concern for the future. Retinal vein occlusion is an important cause of visual loss, particularly in elderly patients. With an ageing population, retinal vein occlusion is likely to become more common. This review discusses current treatments and emerging treatments for diabetic retinopathy, diabetic maculopathy, central retinal vein occlusion and branch retinal vein occlusion. It is essential that community optometrists keep up to date with new treatments and be aware of when patients should be optimally referred.
     
             
            
                
            
         
     
         
        
            
                
                
                    
    
    
        
    
Sign in to view the article    
    
        Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
     
     
 
                 
             
         
     
    
    
        
        Related further reading
        
                
                    
    
            
                
            
        
            
            The clinical figures that count.
            
         
     
 
                 
                
                    
    
            
                
            
        
            
            A glance at what’s happening in the world of technology.
            
         
     
 
                 
                
                    
    
            
                
            
        
            
            We speak to the new Acuity Clinical Editor Chris Steele FCOptom about the evolving role of the optometrist, and his role in that evolution.